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Abstract
Ring-opening metathesis (ROM) of various unsaturated, constrained bicyclic ring systems has been investigated with the use of
commercial ruthenium-based catalysts. Starting from various cyclodienes, the corresponding derived bicyclic lactone, lactam, and
isoxazoline derivatives were submitted to ROM under ethenolysis. These functionalized, strained bicyclic systems afforded novel
highly-functionalized diolefinated heterocyclic scaffolds in ROM reactions with stereocontrol, through the conservation of the con-
figuration of the stereogenic centers of the starting compounds.
Introduction
Metathesis reactions, among them ring-opening metathesis
(ROM), have received a great deal of attention in synthetic
organic chemistry, affording access to various highly functio-
nalized, alkenylated molecular entities [1-10].
Highly functionalized three-dimensional organic scaffolds with
multiple stereogenic centers as small molecular entities repre-
sent an important segment of organic and pharmaceutical chem-
istry. Therefore, selective syntheses with stereocontrol of such
scaffolds [11,12], such as highly-functionalized olefinated de-
rivatives [13], are of main importance and a major challenge in
synthetic organic chemistry. Thus, ring-opening metathesis is a
powerful and widely applied methodology for the synthesis of
such derivatives, including alkenylated molecular scaffolds with
multiple stereogenic centers [14-16] and references cited
therein. Diversity-oriented synthesis (DOS), with the aim of the
preparation of structurally diverse elements of small molecules,
has become increasingly important in drug research, and well
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Scheme 1: ROM of various bicyclic unsaturated β-lactams [14-16].
Scheme 2: ROM of various constrained bicyclic unsaturated systems (γ-lactones, δ-lactones, γ-lactam, isoxazoline).
recognized as a common approach to generate molecular
libraries. Results with respect to the various strategies
utilized in DOS with special focus on selective and stereocon-
trolled methods have been published [17-20]. The major
features of these studies are the use of readily available
and easily accessible starting materials towards the
construction of diverse and complex scaffolds and the
application of the resulting compound collections in drug
discovery.
Since their ring C–C double bond offers a number of possible
chemical transformations, cyclic dienes with different ring sizes
might be considered to be important starting materials for the
generation of structurally diverse molecules. Among the large
number of possible transformations, the ring olefinic bond of
alicyclic dienes may lead to valuable β-lactams [21-23] or
γ-lactams [24], shown to be highly important precursors for the
access of various structures (e.g., amino acids, azido esters,
hydroxylated amino esters, fluorinated amino esters, etc.) with
various functional groups as well as stereochemical and skeletal
diversity [21-23].
Results and Discussion
Recently, we have demonstrated the high utility of various con-
strained cyclic dienes, such as norbornadiene as well as 1,5- and
1,3-cyclooctadienes in the context of their applicability towards
the access of diverse, highly functionalized olefinated mole-
cules [14-16]. The corresponding β-lactams derived from cyclo-
dienes were used as starting substances for further functionali-
zation with ROM. We have described a stereocontrolled synthe-
tic route to access difunctionalized cyclic β-amino acid deriva-
tives [14] and β-lactams [15,16] based on ring-opening metathe-
sis (ROM) through ethenolysis of the structurally restricted
cycloalkene β-amino acids or unsaturated bicyclic β-lactams,
followed by cross-coupling metathesis (CM) of the newly
created C–C double bonds (Scheme 1).
Our current goal was to expand the study of the ROM protocol
of functionalized strained ring systems to the investigation of
functionalized derivatives such as bicyclic lactones, γ-lactams
or isoxazolines, derived from various cyclodienes and to eval-
uate their chemical behavior under Ru-catalyzed ring-opening
conditions (Scheme 2).
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Figure 1: Commercial Ru-based catalysts used in the current work.
Scheme 3: ROM of lactones (±)-3 and (±)-4.
Table 1: Isolated yields for compound (±)-5 formed in the ring-opening reaction of lactone (±)-3 with ethylene in ROM reactions with various catalysts.
catalyst G-1 catalyst G-2 catalyst HG-1 catalyst HG-2 catalyst
product
(±)-5 0% 21% 0% 25%
Table 2: Isolated yields for compound (±)-6 formed in the ring-opening reaction of lactone (±)-4 with ethylene in ROM reactions with various catalysts.
catalyst G-1 catalyst G-2 catalyst HG-1 catalyst HG-2 catalyst
product
(±)-6 0% 26% traces 36%
First, the ring opening of racemic bicyclic γ-lactone (±)-3
(derived from cyclodiene 1 via β-lactam (±)-2) [25] was investi-
gated. Ring opening was performed in ethylene atmosphere at
20 °C in the presence of four commercially available Ru-based
catalysts (5 mol %, Figure 1). Note that based on our earlier
results [15], bicyclic unsaturated lactam (±)-2 bearing the
azetidinone ring fused with a six-membered ring system thus
possessing ring strain, did not afford any ROM products. Inter-
estingly, lactone (±)-3 in the presence of second generation
catalysts (G-2 and HG-2) provided the corresponding ring-
opened compound (±)-5 albeit with modest yields (Scheme 3,
Table 1).
In the presence of G-2 and HG-2 catalysts, bicyclic lactone
(±)-4 a stereoisomer of (±)-3 furnished olefinated γ-lactone
(±)-6 similar to (±)-5 (Scheme 3, Table 2). Unfortunately, ROM
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Scheme 4: ROM of lactones (±)-9.
Table 3: Isolated yields for compound (±)-10 formed in the ring-opening reaction of lactone (±)-9 with ethylene in ROM reactions with various cata-
lysts.
catalyst G-1 catalyst G-2 catalyst HG-1 catalyst HG-2 catalyst
product
(±)-10 0% 16% traces 35%
reactions, however, took place with total conversions, they were
always accompanied by the formation of a significant amount
of polymeric materials (ROMP) responsible for the observed
modest yields of these reactions. Noteworthy, neither the varia-
tion of the catalyst loading (amount or in portion) nor the sub-
strate concentration (in 5, 10, 20 or 30 mL of solvent) had any
significant influence on the yield of the products.
Next, racemic lactone (±)-9 (synthesized from 1,3-cyclohexa-
diene (7) through lactam (±)-8) [26] was subjected to ring-
opening reactions with all four catalysts.
It should be noted again, that based on our earlier findings [15],
bicyclic lactam (±)-8 did not provide any ring-opened product,
while bicyclic lactone (±)-9 could be opened with G-2 and
HG-2 catalysts (5 mol %) affording olefinated amino lactone
(±)-10 at 20 °C. Notably, the yield of the transformation with
catalyst HG-2 to obtain lactone derivative (±)-10 was twice as
high as in the case of G-2 (Scheme 4, Table 3).
From the above comparative results it may be assumed that
unsaturated bicyclic β-lactams (±)-2 and (±)-8, bearing the
fused four-membered and six-membered ring system, have a
lower ring strain than bicyclic, unsaturated γ-lactones (±)-3,
(±)-4 and (±)-9. Because of their higher constraint, the latter
compounds underwent ring opening providing the correspond-
ing monocyclic, dialkenylated amino lactones, albeit with
modest yields (Scheme 5); (for relevant literature date for the
ROM for various cyclic systems with ring strain see ref.
[27-29].
We continued our ring-opening investigations with other model
derivatives possessing a larger ring system. According to results
published previously [15] and in contrast with bicyclic cyclo-
hexene-fused lactams (±)-2 and (±)-8, lactam (±)-12 [30],
derived from 1,5-cyclooctadiene, afforded the corresponding
dialkenylated ring-opened product under ROM protocol.
The isolated yields of (±)-15 were higher than those of the anal-
ogous cyclohexene systems in the presence of both G-2 and
HG-2 catalysts because of the higher ring strain of the eight-
membered framework. Bicyclic, unsaturated bridged lactone
(±)-14 (derived from (±)-12) underwent ring-opening not only
with second generation catalysts but also with HG-1 (5 mol %),
leading at 20 °C to δ-lactone derivative (±)-15 although with
low yield (Scheme 6, Table 4). In continuation, we selected a
cyclooctene-fused system, namely isoxazoline (±)-16 which, in
turn, was accessed through nitrile–oxide dipolar cycloaddition,
by using nitroethane, DMAP and Boc2O.
Ring opening proved to be successful with second generation
catalysts, yielding the corresponding diolefinated isoxazoline
(±)-17 (Scheme 6).
Our studies were continued with the ROM reactions of confor-
mationally restricted γ-lactam (±)-18 (Vince’s lactam) as model
compound [24]. The ring opening in ethylene atmosphere of
bridged pyrrolidinone (±)-18 took place at 20 °C and afforded
the corresponding divinylated lactam (±)-19 [31,32]. Some-
what surprisingly, in contrast to model derivatives used previ-
ously, the highest yield (70%) was attained with first genera-
tion catalyst HG-1 (5 mol %). In the presence of the second
generation catalysts, in turn, the ring-opened pyrrolidinone de-
rivative (±)-19 could be isolated only in low yields (Scheme 7,
Table 5).
As observed, the ROM reactions of the investigated unsatu-
rated cyclic substrates (namely (±)-3, (±)-4, (±)-9, (±)-14,
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Scheme 5: ROM of structurally constrained bicyclic lactones and lactams.
Scheme 6: ROM of bridged lactone (±)-14 and cyclooctene-fused isoxazoline (±)-16.
Table 4: Isolated yields for compounds formed in the ring-opening reaction of lactone (±)-14 and isoxazoline (±)-16 with ethylene in ROM reactions
with various catalysts.
catalyst G-1
catalyst
G-2
catalyst
HG-1
catalyst
HG-2
catalyst
product
(±)-15 0% 52% 11% 59%
(±)-17 38% – – 0%
(±)-16 and (±)-18) gave different results in view of the used
Ru-based catalyst, which allowed us to conclude that all these
transformations are highly substrate and catalyst dependent, the
nature of the structure of the cyclic starting material deter-
mining the outcome of the transformations. It is well known
that the prediction of the behavior of the catalyst efficiency is a
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Scheme 7: ROM and transformations of lactam (±)-18.
Table 5: Isolated yields for compound (±)-19 formed in the ring-opening reaction of lactam (±)-18 with ethylene in ROM reactions with various cata-
lysts.
catalyst G-1 catalyst G-2 catalyst HG-1 catalyst HG-2 catalyst
product
(±)-19 9% 29% 70% 15%
rather difficult task. Metathesis reactions are known to be often
catalyst or substrate dependent. Electronic or steric factors, and
chelation effects may contribute to the outcome of metathesis in
view of the yield. Moreover, possible H-bonding interactions in
the intermediate phase between the catalyst chlorine and the
substrate may be responsible for the accomplishments of the
reactions, which were deeply investigated and discussed in the
literature [33-37] and see references therein. In our case it was
observed that the imidazole carbene-based catalysts (G-2 and
HG-2) were effective in case of bridged lactones with a six-
membered ring part in their framework, with O-functionalities
(±)-3, (±)-4, (±)-9 and (±)-14. In case of isoxazoline-fused de-
rivative (±)-16 G-1 gave the best result, while in case of lactam
(±)-18 HG-1 was the most efficient. The observed results
regarding the current ROM processes were somewhat
surprising, the overall comparison of these experimental investi-
gations in the ROM may depend strongly on the structure of the
substrates.
The valuable dialkenylated compounds (lactones, lactams, isox-
azolines) with multiple stereogenic centers thus synthesized can
be considered interesting scaffolds for further transformations
in view of the access of novel three-dimensional functionalized
scaffolds through cross-metathesis (CM). An illustrative exam-
ple is shown on Scheme 7. Divinylated γ-lactam (±)-19 selected
as a model compound was first subjected to CM with methyl
acrylate. When the reaction was performed in the presence of
Ru-based catalysts, in CH2Cl2, either at reflux temperature or at
20 °C, it gave a mixture of monometathesised products ((±)-21
and (±)-22) after 6 h together with a large amount of polymeric
materials.
The products could not be separated by means of chromatogra-
phy. Interestingly, however, the CM of (±)-19 with methyl vinyl
ketone induced by G-2, HG-1 or HG-2, afforded a single deriv-
ative, monometathesised compound (±)-20 bearing the oxo
group closest to the amide N-atom (Scheme 7, Table 6). Com-
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Table 6: Isolated yields for compound (±)-20 formed in the reaction of lactam (±)-19 in CM reactions with various catalysts.
catalyst G-1 catalyst G-2 catalyst HG-1 catalyst HG-2 catalyst
product
(±)-20 0% 5% 19% 28%
pound (±)-20 was formed in low yields and E-selectively with
the chemodiscrimination of the olefinic bonds. The observed
low yields for the formation of (±)-20 might be explained by
stereoelectronic factors. The coordinating ability of both the
O- and N-atom of the amide with the Ru atom in the metalla-
cyclobutane intermediate may reduce the reactivity of the
olefinic bonds. Furthermore, the chelating ability of the amide
heteroatoms is also assumed to be responsible for the chemodis-
crimination of the vinyl groups. Namely, the chelating five-
membered structure T1 is more favored than T2 and, therefore,
the vinyl group closest to the ring N-atom becomes more reac-
tive in cross-metathesis (Figure 2).
Figure 2: Chelate intermediates in CM of (±)-19.
Similar chemodiscriminations of C–C double bonds were previ-
ously observed in the transformation of various alkenylated
lactams or amino esters [16]. Lactams are known to be useful
precursors for the preparation of amino acids and amino esters
[21,22]. When compound (±)-19 was subjected to either acid-
catalyzed hydrolysis or ethanolysis at reflux, it furnished a
pyrrolidinone derivative identified as (±)-23, instead of the ex-
pected product (amino acids or amino ester) formed via the
opening of the heteroring, (Scheme 7). The process involves
isomerization through olefin bond migration proceeding
Z-selectively.
Conclusion
The ring-opening metathesis (ROM) of some ring-constrained,
unsaturated bicyclic frameworks has been studied in the
presence of commercially available ruthenium-based
catalysts. The bicyclic systems, derived from various cyclodi-
enes, such as lactone, lactam or isoxazoline derivatives,
were investigated under ROM through ethenolysis, which
afforded novel dialkenylated scaffolds formed under
stereocontrol with the conservation of the configuration
of the stereogenic centers. The resulting diolefinated aminolac-
tones, isoxazolines or lactam derivatives with multiple stereo-
genic centers might be considered to be interesting highly-func-
tionalized three-dimensional compounds for further derivatiza-
tions. Extensions of the ROM of various bicyclic, conforma-
tionally restricted derivatives are currently being studied by our
group.
Experimental
General procedure for the ring-opening
metathesis
To a solution of bicyclic olefin derivative (150 mg) in an-
hydrous CH2Cl2 (20 mL) the catalyst (5 mol %) was added (see
Tables) and the mixture was stirred at 20 °C in the presence of
an ethylene atmosphere for the time indicated in the text (moni-
tored by TLC). After completion of the reaction, the mixture
was concentrated under vacuum and purified by column chro-
matography on silica gel (n-hexane/EtOAc).
General procedure for cross-metathesis
To a solution of γ-lactam derivative (80 mg) in anhydrous
CH2Cl2 (15 mL), catalyst (5 mol %, see Table) and methyl
vinyl ketone or methyl acrylate (4 equiv) were added and the
mixture was stirred for the time and temperature indicated in
text. After completion of the reaction (monitored by TLC), the
mixture was concentrated under vacuum and the residue was
purified by column chromatography on silica gel (n-hexane/
EtOAc).
General procedure for the nitrile–oxide
cycloaddition
To a solution of 1,5-cyclooctadiene (1.5 mmol) in THF
(20 mL), EtNO2 (5 equiv), DMAP (0.3 mmol, 20 mol %) and
Boc2O (4.5 mmol, 3 equiv) were added and the mixture was
stirred at 20 °C for 24 h. The reaction mixture was then diluted
with H2O (30 mL) and extracted with EtOAc (3 × 15 mL). The
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combined organic layer was washed with brine (2 × 20 mL),
dried (Na2SO4) and concentrated under vacuum. The crude
residue was purified by column chromatography on silica gel
(n-hexane/EtOAc).
Characterization of the synthesized substances
tert-Butyl ((S*)-1-((3R*,5S*)-2-oxo-5-vinyltetrahydrofuran-
3-yl)allyl)carbamate ((±)-5).
Yellow oil; yield 25%; Rf 0.70 (n-hexane/EtOAc 2:1); 1H NMR
(CDCl3, 400 MHz) δ 1.41 (s, 9H, t-Bu), 1.82–1.88 (m, 1H,
CH2), 2.40–2.47 (m, 1H, CH2), 2.98–3.06 (m, 1H, H-3),
4.33–4.39 (m, 1H, CHN), 4.78–4.84 (m, 1H, H-5), 5.23–5.32
(m, 4H, CH=), 5.66–5.82 (m, 3H, CH= and NH); 13C NMR
(CDCl3, 100 MHz) δ 29.0, 29.7, 44.7, 52.5, 79.4, 80.1, 118.7,
119.3, 134.8, 135.1, 155.1, 174.2; MS (ESI, pos) (m/z): 288
[M + 1], 168 [M − Boc]; anal. calcd for C14H21NO4: C, 62.90;
H, 7.92; N, 5.24; found, C, 62.55; H, 7.58; N, 4.89.
tert-Butyl ((R*)-1-((3R*,5S*)-2-oxo-5-vinyltetrahydrofuran-
3-yl)allyl)carbamate ((±)-6).
Yellow oil; yield 36%; Rf 0.72 (n-hexane/EtOAc 2:1); 1H NMR
(CDCl3, 400 MHz) δ 1.47 (s, 9H, t-Bu), 1.94–1.99 (m, 1H,
CH2), 2.46–2.51 (m, 1H, CH2), 3.00–3.09 (m, 1H, H-3),
4.48–4.54 (m, 1H, CNH), 4.73–4.85 (m, 2H, H-5 and NH),
5.27–5.33 (m, 3H, CH=), 5.40–5.46 (m, 1H, CH=), 5.77–6.01
(m, 2H, CH=); 13C NMR (CDCl3, 100 MHz) δ 28.9, 29.4, 45.7,
52.0, 79.0, 80.1, 116.8, 118.6, 135.2, 135.7, 155.6, 175.7;
MS (ESI, pos) (m/z): 288 [M + 1], 168 [M − Boc]; anal. calcd
for C14H21NO4: C, 62.90; H, 7.92; N, 5.24; found, C, 62.59; H,
8.30; N, 4.87.
tert-Butyl ((2S*,3R*,4R*)-4-allyl-5-oxo-2-vinyltetrahydro-
furan-3-yl)carbamate ((±)-10).
Yellow oil; yield 35%; Rf 0.70 (n-hexane/EtOAc 2:1); 1H NMR
(CDCl3, 400 MHz) δ 1.48 (s, 9H, t-Bu), 2.42–2.49 (m, 1H,
CH2), 2.53–2.58 (m, 1H, CH2), 2.61–2.67 (m, 1H, H-4),
3.91–3.97 (m, 1H, H-3), 4.52–4.62 (m, 2H, H-2 and NH),
5.06–5.12 (m, 2H, CH=), 5.33–5.38 (m, 1H, CH=), 5.42–5.48
(m, 1H, CH=), 5.75–5.85 (m, 2H, CH=); 13C NMR (CDCl3,
100 MHz) δ 18.9, 22.7, 29.4, 45.7, 57.3, 82.4, 118.8, 119.4,
133.1, 133.2, 154.7, 174.3; MS (ESI, pos) (m/z): 288 [M + 19],
168 [M – Boc]; anal. calcd for C14H21NO4: C, 62.90; H, 7.92;
N, 5.24; found, C, 62.59; H, 7.60; N, 4.86.
tert-Butyl ((1R*,2S*,6S*,Z)-8-oxo-7-oxabicyclo[4.2.2]dec-4-
en-2-yl)carbamate ((±)-14).
White solid; yield 38%; mp 101–102 °C; Rf = 0.50 (n-hexane/
EtOAc 2:1); 1H NMR (CDCl3, 400 MHz) δ 1.40 (s, 9H, t-Bu),
1.68–1.75 (m, 1H, CH2), 1.83–1.99 (m, 2H, CH2), 2.28–2.35
(m, 2H, CH2), 1.42–1.50 (m, 1H, CH2), 3.02–3.06 (m, 1H,
H-1), 3.90–3.99 (m, 1H, H-2), 5.00–5.08 (brs, 1H, NH),
5.10–5.15 (m, 1H, H-6), 5.47–5.53 (m, 1H, H-4), 5.83–5.92 (m,
1H, H-5); 13C NMR (CDCl3, 100 MHz) δ 21.4, 25.3, 28.4,
46.8,  55.6,  78.7,  79.8,  125.9,  129.0,  154.6,  173.0;
MS (ESI, pos) (m/z): 288 [M + 1], 168 [M – Boc]; anal. calcd
for C14H21NO4: C, 62.90; H, 7.92; N, 5.24; found, C, 63.22; H,
7.59; N, 4.88.
tert-Butyl ((S*)-1-((3R*,6S*)-2-oxo-6-vinyltetrahydro-2H-
pyran-3-yl)but-3-en-1-yl)carbamate ((±)-15).
White solid; yield 59%; mp 64–65 °C; Rf 0.65 (n-hexane/
EtOAc 2:1); 1H NMR (CDCl3, 400 MHz) δ 1.42 (s, 9H, t-Bu),
1.67–1.74 (m, 2H, CH2), 1.93–2.02 (m, 2H, CH2), 2.32–2.42
(m, 2H, CH2), 2.74–2.81 (m, 1H, H-3), 3.78–3.85 (m, 1H,
CHN), 4.81–4.86 (m, 1H, CH=), 5.13–5.10 (m, 2H, CH=),
5.25–5.35 (m, 2H, CH=), 5.38 (brs, 1H, NH), 5.69–5.80 (m, 2H,
CH=); 13C NMR (CDCl3, 100 MHz) δ 20.5, 26.3, 27.0,
35.0, 44.0, 51.1, 78.4, 79.2, 117.4, 117.5, 135.5, 135.7, 155.6,
172.8; MS (ESI, pos) (m/z): 296 [M + 1]; anal. calcd for
C16H25NO4: C, 65.06; H, 8.53; N, 4.74; found, C, 64.69; H,
8.19; N, 4.39.
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(3aR*,9aR*,Z)-3-Methyl-3a,4,5,8,9,9a-hexahydrocyclo-
octa[d]isoxazole ((±)-16).
Yellow oil; yield: 62%; Rf 0.37 (n-hexane/EtOAc 4:1);
1H NMR (CDCl3, 400 MHz): δ 1.80–1.87 (m, 2H, H-4), 1.95
(s, 3H, CH3), 2.02–2.19 (m, 3H, H-5, H-8), 2.21–2.36 (m, 1H,
H-8), 2.4–2.54 (m, 1H, H-9), 2.97–3.06 (q, 1H, J1 = 8.64 Hz,
J2 = 8.46 Hz, J3 = 8.64 Hz, H-3a), 4.37–4.45 (m, 1H, H-9a),
5.55–5.64 (m, 1H, H-6), 5.65–5.73 (m, 1H, H-7); 13C NMR
(DMSO, 125 MHz) δ 12.3, 24.4, 24.7, 25.1, 28.5, 51.0, 83.9,
129.0, 130.7, 160.9; anal. calcd for C10H15NO: C, 72.69; H,
9.15; N, 8.48; found, C, 72.38; H, 8.80; N, 8.11.
(4R*,5R*)-4,5-Di(but-3-enyl)-3-methyl-4,5-dihydroisoxazole
((±)-17).
Yellow oil; yield 38%; Rf = 0.57 (n-hexane/EtOAc 4:1);
1H NMR (CDCl3, 400 MHz) δ 1.51–1.74 (m, 4H, CH2), 2.00 (s,
3H, CH3), 2.08–2.19 (m, 3H, CH2), 2.39–2.48 (m, 1H, CH2),
2.97–3.05 (m, 1H, H-4), 4.46–4.52 (m, 1H, H-5), 5.02–5.16 (m,
4H, CH=), 5.68–5.79 (m, 2H, CH=); 13C NMR (DMSO,
125 MHz) δ 12.6, 24.5, 27.6, 30.7, 32.0, 51.0, 81.7, 115.6,
115.8, 138.4, 138.6, 159.8; anal. calcd for C12H19NO: C, 74.57;
H, 9.91; N, 7.25; found, C, 74.20; H, 9.65; N, 6.86.
(3S*,5R*)-3,5-Divinylpyrrolidin-2-one ((±)-19).
White solid; yield 70%; mp 67–68 °C; Rf = 0.40 (n-hexane/
EtOAc 1:2); 1H NMR (CDCl3, 400 MHz) δ 1.65–1.72 (m, 1H,
CH2), 2.47–2.53 (m, 1H, CH2), 3.09–3.18 (m, 1H, H-3),
4.05–4.13 (m, 1H, H-5), 5.13–5.25 (m, 4H, CH=), 5.74–5.81
(m, 1H, CH=), 5.84–5.92 (m, 1H, CH=), 6.00 (brs, 1H, NH);
13C NMR (CDCl3, 100 MHz) δ 34.9, 46.0, 55.2, 116.8, 117.7,
135.0, 138.5, 177.4; MS (ESI, pos) (m/z): 138 [M + 1]; anal.
calcd for C8H11NO: C, 70.04; H, 8.08; N, 10.21; found, C,
69.69; H, 7.81; N, 9.86.
(3S*,5R*)-5-((E)-3-Oxobut-1-en-1-yl)-3-vinylpyrrolidin-2-
one ((±)-20).
White solid; yield 28%; mp 58–89 °C; Rf = 0.45 (n-hexane/
EtOAc 1:2); 1H NMR (CDCl3, 400 MHz) δ 1.75–1.82 (m,1H,
CH2), 2.36 (s, 3H, CH3), 2.53–2.62 (m, 1H, CH2), 3.27–3.35
(m, 1H, H-3), 4.29–4.37 (m, 1H, H-5), 5.27–5.35 (m, 2H,
CH=), 5.88–5.97 (m, 1H, CH=), 6.20–6.27 (d, J = 16.1 Hz, 1H,
CH=), 6.51 (brs, 1H, NH), 6.60–6.68 (dd, J = 16.2 Hz,
J = 6.6 Hz, 1H, CH=); 13C NMR (CDCl3, 100 MHz) δ 27.6,
34.1, 45.7, 53.4, 118.2, 130.5, 134.3, 145.3, 177.7, 197.7;
MS (ESI, pos) (m/z): 181 [M + 1]; anal. calcd for C10H13NO2:
C, 67.02; H, 7.31; N, 7.82; found, C, 67.33; H, 7.01; N, 7.52.
(R*,Z)-3-Ethylidene-5-vinylpyrrolidin-2-one ((±)-23).
White solid; yield 69%; mp 49–50 °C; Rf = 0.35 (n-hexane/
EtOAc 1:2); 1H NMR (CDCl3, 400 MHz) δ 1.77 (d, J = 6.9 Hz,
3H, CH3), 2.45–2.51 (m, 1H, CH2), 2.98–3.04 (m, 1H, CH2),
4.19–4.28 (m, 1H, H-5), 5.02–5.08 (d, J =10.1 Hz, 1H, CH=),
5.20–5.27 (d, J =16.6 Hz, 1H, CH=), 5.78–5.88 (m 1H, CH=),
6.48–6.54 (m, 1H, CH=), 7.51 (brs, 1H, NH); 13C NMR
(CDCl3, 100 MHz) δ 14.8, 31.2, 53.9, 115.6, 128.6, 131.5,
139.2, 171.5; MS (ESI, pos) (m/z): 138 [M + 1]; anal. calcd for
C8H11NO: C, 70.04; H, 8.08; N, 10.21; found, C, 69.70; H,
7.80; N, 9.84.
Supporting Information
Supporting Information File 1
Copies of NMR spectra.
[https://www.beilstein-journals.org/bjoc/content/
supplementary/1860-5397-14-247-S1.pdf]
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